Q: How do I get involved?

Whether you’re a researcher, journalist, developer, or longevity enthusiast, we welcome your participation. Email us at contact@longevityone.org to explore partnerships, media opportunities, or to join our contributor network.

Question 1

What is LongevityOne?

Accepted Answer

LongevityOne is a global platform dedicated to curing human aging. We consolidate advanced research, emerging technology, and unified data to accelerate innovation in the longevity space. Our mission is to serve scientists, bio-hackers, and advocates with trustworthy resources and collaborative tools.

Question 2

Who founded LongevityOne?

Accepted Answer

LongevityOne was founded by Michael Peres, a serial entrepreneur and biomedical researcher with a background in Mathematics, Computer Science, and Jewish Studies. He is currently pursuing Biomedical Engineering to strengthen the technical foundation of LongevityOne’s work. Learn more about him at michaelperes.com.

Question 3

What makes LongevityOne different?

Accepted Answer

We don’t just report on breakthroughs — we unify them. LongevityOne acts as a central repository where research, news, tools, and contributors converge. By removing silos in the aging research ecosystem, we accelerate progress toward reversing age-related decline.

Question 4

Who is LongevityOne for?

Accepted Answer

Our platform is built for:Researchers in biotechnology, genetics, and agingMedical professionals and institutionsBio-hackers and health optimizersInvestors in life-extension technologiesPublic advocates for healthy aging

Question 5

What are your long-term goals?

Accepted Answer

Our core objective is to contribute to the development of a foundational cure for aging. We aim to reshape the human experience of aging by supporting breakthrough research, increasing public understanding, and fostering international collaboration over the next 15 years.

Question 6

How do I get involved?

Accepted Answer

Whether you&#8217;re a researcher, journalist, developer, or longevity enthusiast, we welcome your participation. Email us at contact@longevityone.org to explore partnerships, media opportunities, or to join our contributor network.

Researchers Crack Decades-Old Chemistry Challenge

New Artificial Neurons Physically Replicate the Brain

Scientists Develop Floating Device That Harvests Energy From Raindrops

Obesity Treatment Becoming “Two-Tier System,” Experts Warn

New Study: Helping Others Slows Cognitive Decline by Up to 20%

100x More Potent: Chemists Discover Powerful New Antibiotic “Hidden in Plain Sight”

Are You Wasting Your Money on Tips? New Study Casts Doubt on Their Effectiveness

Hair Loss

How Oral and Topical Minoxidil Compare for Hair Loss Treatment

Precision DNA Profiling for Next Generation Hair Loss Solutions

The DHT Story in Hair Loss-Still True, but PGD2 Writes a Missing Chapter

Contributors+

Longevity medicine enters med school

mTOR science has skin in the game

Durana Elmi of Cymbiotika secures nationwide retail deal with Target

Anavex Life Sciences reports sustained benefits from oral blarcamesine

Harley Street clinics adopt Cambridge-developed Premaz for brain health protection

Rubedo Life Sciences and SVAX form partnership at Riyadh investment event

Celularity and DefEYE partner to expand regenerative therapies in eye care

Sparrow Bioacoustics raises $10 million to expand cardiac AI rollout

Category 3